Compare Twist Bioscience Corp (TWST) vs 10X Genomics Inc (TXG) Price & Performance

Twist Bioscience CorpTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Twist Bioscience Corp vs 10X Genomics Inc — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Twist Bioscience Corp and 10X Genomics Inc are close in size by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals.

	TWST	TXG
Market Cap	$5.45B	$5.48B
Sector	Health	Health
52-Week High	$102.88	$45.80
52-Week Low	$24.16	$11.34
Enterprise Value	$5.37B	$5.02B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TWST

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.